Verrica Pharmaceuticals Inc. (VRCA): Gross Profit

Revenue minus cost of revenue for the same annual period and currency, computed by TickerFacts from the filed figures. The issuer may report gross profit or margin on a different basis.

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

$4.97M
Year ended 2024-12-31
2023-12-31: $4.62M2024-12-31: $4.97M$4.97M
2023-12-31 Gross Profit (USD) 2024-12-31
Period endedGross ProfitChange YoYSource filing
2024-12-31$4.97M+7.4%2026-03-11, From 2024-01-01
2023-12-31$4.62Mn/a2025-03-11, From 2023-01-01